Wird geladen...
In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras–effector interaction
Mutational activation of the Ras oncogene products (H-Ras, K-Ras, and N-Ras) is frequently observed in human cancers, making them promising anticancer drug targets. Nonetheless, no effective strategy has been available for the development of Ras inhibitors, partly owing to the absence of well-define...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
National Academy of Sciences
2013
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3657810/ https://ncbi.nlm.nih.gov/pubmed/23630290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1217730110 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|